Stankov, Karmen
69  results:
Search for persons X
?
2

DPP-4 Inhibitors: Renoprotective Potential and Pharmacokine..:

Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan...
European Journal of Drug Metabolism and Pharmacokinetics.  45 (2019)  1 - p. 1-14 , 2019
 
?
3

Epigenetics in disease etiopathogenesis:

Glavaski, Mila ; Stankov, Karmen
Genetika; ABI Genetika.  51 (2019)  3 - p. 975-994 , 2019
 
?
7

Potential Applications of Gliclazide in Treating Type 1 Dia..:

Mikov, Momir ; Đanić, Maja ; Pavlović, Nebojša...
European Journal of Drug Metabolism and Pharmacokinetics.  43 (2017)  3 - p. 269-280 , 2017
 
?
8

The Role of Drug Metabolites in the Inhibition of Cytochrom..:

Mikov, Momir ; Đanić, Maja ; Pavlović, Nebojša...
European Journal of Drug Metabolism and Pharmacokinetics.  42 (2017)  6 - p. 881-890 , 2017
 
?
10

Bile acid signaling through farnesoid X and TGR5 receptors ..:

Stanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir
Hepatobiliary & Pancreatic Diseases International.  14 (2015)  1 - p. 18-33 , 2015
 
?
 
?
12

Cytotoxicity of single-walled carbon nanotubes to human lun..:

Jojic, Nikola ; Kojic, Vesna ; Kojic, Danijela..
Archive of Oncology; Arhiv za onkologiju.  21 (2013)  2 - p. 59-61 , 2013
 
?
13

Probiotics—Interactions with Bile Acids and Impact on Chole..:

Pavlović, Nebojša ; Stankov, Karmen ; Mikov, Momir
Applied Biochemistry and Biotechnology.  168 (2012)  7 - p. 1880-1895 , 2012
 
?
15

The Impact of Farnesoid X Receptor Activation on Intestinal..:

Stojancevic, Maja ; Stankov, Karmen ; Mikov, Momir
Canadian Journal of Gastroenterology.  26 (2012)  9 - p. 631-637 , 2012
 
1-15